EE200100375A - Telmisartan polymorphs, methods for their preparation and their use in the manufacture of a medicament - Google Patents
Telmisartan polymorphs, methods for their preparation and their use in the manufacture of a medicamentInfo
- Publication number
- EE200100375A EE200100375A EEP200100375A EEP200100375A EE200100375A EE 200100375 A EE200100375 A EE 200100375A EE P200100375 A EEP200100375 A EE P200100375A EE P200100375 A EEP200100375 A EE P200100375A EE 200100375 A EE200100375 A EE 200100375A
- Authority
- EE
- Estonia
- Prior art keywords
- medicament
- manufacture
- preparation
- methods
- telmisartan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19901921A DE19901921C2 (en) | 1999-01-19 | 1999-01-19 | Polymorphs of telmisartan, process for their preparation and their use in the manufacture of a medicament |
PCT/EP2000/000065 WO2000043370A1 (en) | 1999-01-19 | 2000-01-07 | Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
EE200100375A true EE200100375A (en) | 2002-10-15 |
EE04344B1 EE04344B1 (en) | 2004-08-16 |
Family
ID=7894715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200100375A EE04344B1 (en) | 1999-01-19 | 2000-01-07 | Telmisartan polymorphs, methods for their preparation and their use in the preparation of a medicament |
Country Status (36)
Country | Link |
---|---|
EP (1) | EP1144386B1 (en) |
JP (1) | JP4700813B2 (en) |
KR (1) | KR100658959B1 (en) |
CN (1) | CN1144790C (en) |
AR (1) | AR035475A1 (en) |
AT (1) | ATE252564T1 (en) |
AU (1) | AU765081B2 (en) |
BG (1) | BG65027B1 (en) |
BR (1) | BR0007584A (en) |
CA (1) | CA2352436C (en) |
CO (1) | CO5150238A1 (en) |
CZ (1) | CZ297412B6 (en) |
DE (2) | DE19901921C2 (en) |
DK (1) | DK1144386T3 (en) |
EA (1) | EA003065B1 (en) |
EE (1) | EE04344B1 (en) |
ES (1) | ES2208265T3 (en) |
HK (1) | HK1041485B (en) |
HR (1) | HRP20010514B1 (en) |
HU (1) | HU227401B1 (en) |
IL (2) | IL143634A0 (en) |
MY (1) | MY122755A (en) |
NO (1) | NO319823B1 (en) |
NZ (1) | NZ513528A (en) |
PE (1) | PE20001362A1 (en) |
PL (1) | PL211829B1 (en) |
PT (1) | PT1144386E (en) |
RS (1) | RS50044B (en) |
SA (1) | SA99200838B1 (en) |
SK (1) | SK285429B6 (en) |
TR (1) | TR200102074T2 (en) |
TW (1) | TWI280241B (en) |
UA (1) | UA56358C2 (en) |
UY (1) | UY25980A1 (en) |
WO (1) | WO2000043370A1 (en) |
ZA (1) | ZA200104771B (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10153737A1 (en) * | 2001-10-31 | 2003-05-28 | Boehringer Ingelheim Pharma | Crystalline sodium salt of telmisartan, process for its preparation and its use for the manufacture of a medicament |
US6737432B2 (en) | 2001-10-31 | 2004-05-18 | Boehringer Ingelheim Pharma Kg | Crystalline form of telmisartan sodium |
RS52012B (en) † | 2002-01-16 | 2012-04-30 | Boehringer Ingelheim Pharma Gmbh&Co.Kg. | Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof |
DE10314702A1 (en) | 2003-03-31 | 2004-10-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Process for the preparation of telmisartan |
GB2414019A (en) * | 2004-05-11 | 2005-11-16 | Cipla Ltd | One-step preparation of telmisartan by condensation and hydrolysis |
KR20070061583A (en) | 2004-10-15 | 2007-06-13 | 테바 파마슈티컬 인더스트리즈 리미티드 | Process for preparing telmisartan |
WO2006044754A2 (en) | 2004-10-18 | 2006-04-27 | Dr. Reddy's Laboratories Ltd. | Process for preparing telmisartan |
US8637078B2 (en) | 2005-11-24 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Bilayer tablet comprising telmisartan and diuretic |
EP1908469A1 (en) | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
DE102008059206A1 (en) | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic |
MX346039B (en) | 2009-05-20 | 2017-03-03 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical oral telmisartan solution. |
PL2443094T3 (en) | 2009-06-19 | 2013-08-30 | Krka Tovarna Zdravil D D Novo Mesto | Process for the preparation of telmisartan |
EP2277866A1 (en) | 2009-06-22 | 2011-01-26 | Inke, S.A. | Process for preparing telmisartan |
WO2011002423A2 (en) | 2009-07-02 | 2011-01-06 | Mahmut Bilgic | Solubility enhancing pharmaceutical composition |
EP2448575A2 (en) | 2009-07-02 | 2012-05-09 | Bilgic Mahmut | Pharmaceutical composition increasing solubility and stability |
EA025946B1 (en) | 2010-10-27 | 2017-02-28 | Крка, Товарна Здравил, Д. Д., Ново Место | Multilayer pharmaceutical composition comprising telmisartan and amlodipine |
ITMI20102416A1 (en) * | 2010-12-27 | 2012-06-28 | Chemelectiva S R L | INTERMEDIATE FOR THE PREPARATION OF AN ACTIVE PRINCIPLE AND PROCESS FOR ITS PREPARATION |
EP2612658A1 (en) | 2012-01-05 | 2013-07-10 | Laboratorios Lesvi, S.L. | Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide |
JP6147546B2 (en) * | 2013-04-10 | 2017-06-14 | 株式会社トクヤマ | Method for producing telmisartan A-type crystals with reduced acetic acid |
EP2979691A1 (en) | 2014-07-30 | 2016-02-03 | Boehringer Ingelheim International GmbH | Oral disintegrating tablet |
JP6275596B2 (en) * | 2014-09-03 | 2018-02-07 | 株式会社トクヤマ | Method for producing ammonium salt of telmisartan |
JP5871294B1 (en) | 2015-02-27 | 2016-03-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Immediate release oral tablets |
KR20170001921A (en) | 2015-06-26 | 2017-01-05 | 대원제약주식회사 | A pharmaceutical composition comprising telmisartan with increased stability and a preparation method thereof |
KR20170012703A (en) | 2015-07-22 | 2017-02-03 | 대원제약주식회사 | A pharmaceutical composition comprising telmisartan and a preparation method thereof |
US20200316029A1 (en) | 2016-05-30 | 2020-10-08 | Boehringer Ingelheim International Gmbh | Fixed dose combination of telmisartan, hydrochlorothiazide and amlodipine |
KR102044223B1 (en) * | 2016-09-12 | 2019-11-13 | 성균관대학교산학협력단 | Solid dispersions comprising Telmisartan and the preparation method thereof |
CN106749037B (en) * | 2016-12-21 | 2019-06-21 | 山东大学 | A kind of unformed Telmisartan-glutaric acid eutectic and its preparation method and application |
CN106749036B (en) * | 2016-12-21 | 2019-06-21 | 山东大学 | A kind of unformed Telmisartan-pimelic acid eutectic and its preparation method and application |
CA3067918A1 (en) | 2017-07-07 | 2019-01-10 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats |
CN109851562A (en) * | 2019-01-30 | 2019-06-07 | 浙江省食品药品检验研究院 | A kind of Telmisartan crystal and preparation method thereof |
WO2023001880A1 (en) | 2021-07-22 | 2023-01-26 | Krka, D. D., Novo Mesto | Bilayer tablet comprising telmisartan and indapamide |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI9210098B (en) * | 1991-02-06 | 2000-06-30 | Dr. Karl Thomae | Benzimidazoles, drugs with this compounds, and process for their preparation |
US5139114A (en) * | 1991-03-18 | 1992-08-18 | Abex Corporation | Visible brake block wear indicator |
-
1999
- 1999-01-19 DE DE19901921A patent/DE19901921C2/en not_active Expired - Fee Related
- 1999-12-17 PE PE1999001284A patent/PE20001362A1/en not_active Application Discontinuation
- 1999-12-26 SA SA99200838A patent/SA99200838B1/en unknown
-
2000
- 2000-01-07 PL PL349425A patent/PL211829B1/en unknown
- 2000-01-07 HU HU0105148A patent/HU227401B1/en not_active IP Right Cessation
- 2000-01-07 IL IL14363400A patent/IL143634A0/en active IP Right Grant
- 2000-01-07 KR KR1020017008958A patent/KR100658959B1/en not_active IP Right Cessation
- 2000-01-07 EA EA200100730A patent/EA003065B1/en not_active IP Right Cessation
- 2000-01-07 AU AU22881/00A patent/AU765081B2/en not_active Ceased
- 2000-01-07 AT AT00901510T patent/ATE252564T1/en active
- 2000-01-07 CZ CZ20012634A patent/CZ297412B6/en not_active IP Right Cessation
- 2000-01-07 JP JP2000594786A patent/JP4700813B2/en not_active Expired - Lifetime
- 2000-01-07 DK DK00901510T patent/DK1144386T3/en active
- 2000-01-07 NZ NZ513528A patent/NZ513528A/en not_active IP Right Cessation
- 2000-01-07 PT PT00901510T patent/PT1144386E/en unknown
- 2000-01-07 CA CA2352436A patent/CA2352436C/en not_active Expired - Fee Related
- 2000-01-07 CN CNB00802880XA patent/CN1144790C/en not_active Expired - Fee Related
- 2000-01-07 EP EP00901510A patent/EP1144386B1/en not_active Expired - Lifetime
- 2000-01-07 SK SK1020-2001A patent/SK285429B6/en not_active IP Right Cessation
- 2000-01-07 BR BR0007584-1A patent/BR0007584A/en active Pending
- 2000-01-07 EE EEP200100375A patent/EE04344B1/en not_active IP Right Cessation
- 2000-01-07 WO PCT/EP2000/000065 patent/WO2000043370A1/en active IP Right Grant
- 2000-01-07 ES ES00901510T patent/ES2208265T3/en not_active Expired - Lifetime
- 2000-01-07 TR TR2001/02074T patent/TR200102074T2/en unknown
- 2000-01-07 RS YUP-511/01A patent/RS50044B/en unknown
- 2000-01-07 DE DE50004150T patent/DE50004150D1/en not_active Expired - Lifetime
- 2000-01-17 TW TW089100637A patent/TWI280241B/en not_active IP Right Cessation
- 2000-01-17 MY MYPI20000130A patent/MY122755A/en unknown
- 2000-01-18 CO CO00002435A patent/CO5150238A1/en unknown
- 2000-01-18 UY UY25980A patent/UY25980A1/en not_active Application Discontinuation
- 2000-01-19 AR ARP000100241A patent/AR035475A1/en active Pending
- 2000-07-01 UA UA2001085811A patent/UA56358C2/en unknown
-
2001
- 2001-06-07 IL IL143634A patent/IL143634A/en not_active IP Right Cessation
- 2001-06-12 ZA ZA200104771A patent/ZA200104771B/en unknown
- 2001-06-27 BG BG105654A patent/BG65027B1/en active Active
- 2001-07-10 HR HR20010514A patent/HRP20010514B1/en not_active IP Right Cessation
- 2001-07-18 NO NO20013560A patent/NO319823B1/en not_active IP Right Cessation
-
2002
- 2002-04-24 HK HK02103090.1A patent/HK1041485B/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200100375A (en) | Telmisartan polymorphs, methods for their preparation and their use in the manufacture of a medicament | |
EE200100431A (en) | 16-haloepothilone derivatives, process for their preparation and pharmaceutical use | |
EE200300048A (en) | Benzimidazole derivatives, their preparation and therapeutic use | |
EE04236B1 (en) | Benzimidazoles, their preparation and use as medicaments | |
EE200200602A (en) | Long-acting beta-mimetics, a process for their preparation and their use as medicaments | |
EE04565B1 (en) | Adamantane derivatives, their preparation and use | |
EE04464B1 (en) | Indalyl-substituted benzenecarboxamides, process for their preparation, use and pharmaceutical compositions | |
NO2013004I1 (en) | axitinib, optionally in the form of a pharmaceutical accentible salt | |
EE200100470A (en) | Pyridopyranoazepine derivatives, their preparation and therapeutic use | |
EE200200064A (en) | Arylmethylcarbonylaminothiazole derivatives, their preparation and their use as anticancer agents | |
EE200000037A (en) | Acylpiperazinylpyrimidines Derivatives, Their Preparation and Use as Medicaments | |
IL149400A0 (en) | Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments | |
EE200100422A (en) | Epothilone derivatives, process for their preparation and pharmaceutical use | |
NO20015148L (en) | New pharmaceutical preparation | |
PT1200444E (en) | NEW XANTONE COMPOUNDS, ITS PREPARATION AND ITS USE AS A DRUG | |
NO20015104D0 (en) | New pharmaceutical preparation | |
EE04837B1 (en) | Echinocandin derivatives, process for their preparation and use as antimycotics | |
NO20015105D0 (en) | New pharmaceutical preparation | |
SI1144386T1 (en) | Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament | |
FI991396A0 (en) | 5-substituted 3-hydroxybenzoates, process for their preparation and their use | |
IT1312082B1 (en) | MORPHINOID DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC USE. | |
IT246525Y1 (en) | COMPOSITE MANUFACTURE PERFECTED FOR USE IN BUILDING | |
FI20002361A (en) | A process for preparing a pharmaceutical composition and the use of the composition | |
FI20002362A (en) | A process for preparing a pharmaceutical composition and the use of the composition | |
SI1309594T1 (en) | Benzimidazole derivatives, preparation and therapeutic use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC1A | Change of owner name | ||
KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
MM4A | Lapsed by not paying the annual fees |
Effective date: 20150107 |